Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Galena Biopharma In (GALE)

Galena Biopharma In (GALE)
0.26 -0.02 (-7.14%) 12/29/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Fri, Dec 29th, 2017
Day Low
0.26
Day High
0.40
Open 0.29
Previous Close 0.28 0.28
Volume 20,353,201 20,353,201
Avg Vol 1,645,400 1,645,400
Stochastic %K 30.95% 30.95%
Weighted Alpha -71.76 -71.76
5-Day Change -0.01 (-5.45%) -0.01 (-5.45%)
52-Week Range 0.26 - 2.41 0.26 - 2.41
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,885
  • Shares Outstanding, K 45,710
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,550 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.69
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.98
  • Most Recent Earnings $-0.19 on 08/14/17
  • Next Earnings Date 11/08/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.58
  • Growth Rate Est. (year over year) +172,341.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.26 unch
on 12/29/17
Period Open: 0.31
0.40 -35.00%
on 12/29/17
-0.05 (-16.40%)
since 11/29/17
3-Month
0.26 unch
on 12/29/17
Period Open: 0.35
0.44 -40.91%
on 10/10/17
-0.09 (-26.35%)
since 09/29/17
52-Week
0.26 unch
on 12/29/17
Period Open: 2.05
2.41 -89.21%
on 02/06/17
-1.79 (-87.32%)
since 12/29/16

Business Summary

Galena Biopharma, Inc. is a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Galena Biopharma, Inc., formally known as RXi Pharmaceuticals Corporation, is based in Portland, Oregon.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.45
1st Resistance Point 0.35
Last Price 0.26
1st Support Level 0.21
2nd Support Level 0.17
3rd Support Level N/A

See More

52-Week High 2.41
Fibonacci 61.8% 1.59
Fibonacci 50% 1.34
Fibonacci 38.2% 1.08
Last Price 0.26
52-Week Low 0.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals